Treatment of Acinetobacter infections.

Authors

Fishbain J, Peleg AY 

Institution

Division of Infectious Diseases, St John Hospital and Medical Center, Detroit, Michigan 48236, USA. Joel.Fishbain@stjohn.org

Source

Clin Infect Dis 2010 Jul 1; 51(1) :79-84.

Abstract

Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.

Mesh

Acinetobacter Infections
Acinetobacter baumannii
Anti-Infective Agents
Drug Resistance, Bacterial
Drug Therapy, Combination
Humans

Language

eng

Pub Type(s)

Journal Article Review

PubMed ID

20504234